TruAlt Bioenergy (TRUALT) – Share Price & Analysis

Price ₹477.05, Market Cap 3.67K (Cr), P/E 38.23x. Score: 0/100.

Financial Ratios PE Ratio Shareholding Dividend Quarterly Results Financial Statements

TruAlt Bioenergy Stock Price Today (NSE: TRUALT)

TruAlt Bioenergy

TRUALTOther Agricultural Products

₹477.05+₹12.75 (+2.75%)

As on 07 Aug 2026, 11:15 am ISTMarket Closed

Fundamental Score

...

TruAlt Bioenergy Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Q: What is the current share price of TruAlt Bioenergy?

TruAlt Bioenergy (TRUALT) trades at ₹477.05 on NSE and BSE. Market cap ₹3.67K (Cr). Educational data only.

Q: What is the P/E ratio of TruAlt Bioenergy?

TruAlt Bioenergy has a P/E of 38.23x vs industry average 19.03x.

Q: What is the Bull Run score for TruAlt Bioenergy?

TruAlt Bioenergy has a Bull Run score of 0/100 based on 25+ financial parameters.

Q: Does TruAlt Bioenergy pay dividends?

TruAlt Bioenergy has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

Q: What is the ROE of TruAlt Bioenergy?

TruAlt Bioenergy has ROE of 8.38%. Higher ROE indicates better use of shareholder equity.

Q: What is the debt-to-equity ratio of TruAlt Bioenergy?

TruAlt Bioenergy has debt-to-equity of 1.09.

Q: Is TruAlt Bioenergy a good investment?

Bull Run gives TruAlt Bioenergy a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.

TruAlt Bioenergy share price today is ₹477.05, up +2.75% on NSE/BSE as of 7 August 2026. TruAlt Bioenergy (TRUALT) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of ₹3.67K (Cr). The 52-week high for TRUALT share price is ₹549.00 and the 52-week low is ₹310.20. At a P/E ratio of 38.23x, TRUALT is currently trading above its industry average P/E of 19.03x. The company has a Return on Equity (ROE) of 8.38% and a debt-to-equity ratio of 1.09.

TruAlt Bioenergy Share Price Chart — NSE/BSE Historical Performance

No data

High

₹477.05

Low

₹411.00

Volume

3.2L

Change

-9.39%

TruAlt Bioenergy — Last 10 Trading Days

Date	Open	High	Low	Close	Volume
7 Aug 26	₹465.05	₹483.90	₹465.00	₹477.05	5.28L (Cr)
6 Aug 26	₹461.55	₹472.30	₹460.40	₹464.30	2.75L (Cr)
5 Aug 26	₹438.00	₹468.05	₹428.35	₹461.55	7.36L (Cr)
4 Aug 26	₹437.40	₹444.00	₹433.05	₹436.70	1.38L (Cr)
3 Aug 26	₹424.90	₹439.00	₹422.50	₹437.85	1.84L (Cr)
31 Jul 26	₹437.00	₹437.00	₹421.05	₹423.00	1.42L (Cr)
30 Jul 26	₹435.00	₹444.00	₹427.25	₹435.80	2.28L (Cr)
29 Jul 26	₹450.00	₹454.70	₹425.50	₹430.15	29.97L (Cr)
28 Jul 26	₹424.60	₹430.80	₹411.00	₹419.15	3.60L (Cr)
27 Jul 26	₹442.00	₹442.00	₹414.20	₹421.25	3.73L (Cr)

TruAlt Bioenergy — Last 12 Months Price History

Month	Open	High	Low	Close	Change
Aug 2026	₹424.90	₹483.90	₹422.50	₹477.05	+12.27%
Jul 2026	₹454.30	₹475.90	₹411.00	₹423.00	-6.89%
Jun 2026	₹487.55	₹542.00	₹451.50	₹453.45	-6.99%
May 2026	₹497.90	₹515.90	₹419.15	₹487.55	-2.08%
Apr 2026	₹414.00	₹508.00	₹399.00	₹492.45	+18.95%
Mar 2026	₹389.00	₹418.00	₹357.00	₹403.40	+3.70%
Feb 2026	₹374.25	₹450.80	₹362.20	₹401.40	+7.25%
Jan 2026	₹406.75	₹417.45	₹310.20	₹381.85	-6.12%
Dec 2025	₹448.95	₹449.00	₹384.00	₹403.85	-10.05%
Nov 2025	₹446.40	₹488.00	₹401.85	₹445.80	-0.13%
Oct 2025	₹545.40	₹549.00	₹439.25	₹446.10	-18.21%

AI Research Briefing

Overvalued ethanol play dependent on continued government support and flawless execution of ambitious expansion plans, micro-cap liquidity a major risk.

Research Confidence

6.0/10Moderate

GOVT CAPEX DARK HORSEConsolidation - 1M: -5.99%.Expensive - P/E of 28.29x vs industry P/E of 21.07x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search. The last significant news was GAIL infusing Million in TruAlt Bioenergy's subsidiary Leafiniti on March 19, 2026. Lock-up agreements for 23,594,844 equity shares ended on March 31, 2026.

CORE STORY (THE REAL GAME)

TruAlt is an ethanol play, riding the government's biofuel blending mandates. The market is pricing in aggressive growth from increased ethanol production and CBG ventures, plus a potential foray into SAF. It's a bet on continued policy support and execution of ambitious expansion plans.

WHAT IS DRIVING THE STOCK

* Ethanol Production: Commissioning of grain integration capex led to a 69.75% QoQ increase in total income to in Q3 FY26.

* CBG Expansion: Plans to develop 24 greenfield CBG units with Sumitomo and GAIL, with 4 expected to be commissioned by July 2026. CBG segment delivered a 63% EBITDA margin for the nine months ended December 31, 2025.

* SAF Opportunity: Progressing with a SAF facility in Andhra Pradesh, targeting in viability gap funding.

BULL vs BEAR

Bull:Government support for ethanol blending continues, driving demand. CBG expansion delivers high margins. SAF foray provides long-term growth potential.

Bear:Recent YoY profit and sales declines of -103.32% and -70.41% respectively in the latest quarter. High debt/equity ratio of 1.1 and low-interest coverage of 2.11x. Promoter selling with a decrease of -17.65%. Valuation is stretched at a P/E of 28.29x vs. an industry P/E of 21.07x.

WHAT MARKET IS PRICING

The market is pricing in flawless execution of CBG and SAF projects and continued policy tailwinds. Any delays, cost overruns, or adverse policy changes will trigger a sharp correction.

BOTTOM LINE

TruAlt is a high-growth, high-risk bet on India's biofuel ambitions. Valuation is rich, and execution risk is substantial. Liquidity is a concern given its micro-cap status.

Why Now

Ethanol blending mandates are supportive
CBG expansion offers high margins
SAF provides long-term optionality

Potential Catalysts

Favorable policy changes for ethanol blending
Successful commissioning of new CBG plants
Securing SAF funding and partnerships

Key Risks

Micro-cap liquidity risk
High debt and low-interest coverage
Promoter selling

Institutional Activity

Promoter selling (Δ -17.65%) signals caution. FII and DII holdings are relatively small, suggesting limited institutional interest.

Macro Context

Government focus on renewable energy and biofuel blending is a tailwind.

Order Book / Expansion

No major news found after live search.

Cash Flow Quality

No Free Cash Flow data available.

3–6 Month Outlook

Next 3-6 months hinge on CBG plant commissioning and progress on SAF project. Watch for policy announcements and execution updates.

Primary Thesis Risk

Policy reversal or execution delays could crater the stock.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

8.38%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

10.44%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

TruAlt Bioenergy Valuation Check

Poor

Price to Earnings (P/E)

38.23x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

19.03x

Average P/E of all peers in this sector

Market-cap Classification

Small-cap

Higher growth potential with higher volatility.

Market Capitalisation

3.67K (Cr)

Total market value of all outstanding shares

Shareholding Pattern

Excellent

Promoter Holding

70.55%

% shares held by company founders/management

Poor

FII Holding

0.66%

% shares held by foreign institutional investors

Average

DII Holding

9.40%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

36.85%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-46.39%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-34.34%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.09x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

1.81x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

TruAlt Bioenergy Fundamental Analysis & Valuation Benchmarking

Educational evaluation of TRUALT across key market metrics for learning purposes.

Positive Indicators

1 factors identified

Balanced Promoter Holding (70.55%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Risk Factors

7 factors identified

Below-Average Return on Equity (8.38%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Profit Decline Concern (-46.39%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-34.34%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Elevated Debt Levels (D/E: 1.09)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Weak Interest Coverage (1.81x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

High Share Pledging Risk (36.85%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

TruAlt Bioenergy vs Other Agricultural Products Peers

Peer Comparison -

Compare TruAlt Bioenergy with 10 other companies in the same sector

11 companies

Company Info	Fundamental Overall score	Valuation Price metrics	Profitability Return metrics		Financial Health Debt management	Growth 5Y performance		Dividend Yield %
Company Company name	Score Bull Run comprehensive fundamental score based on 20+ metrics	Price Current trading price of the stock	Market Cap Total value of all shares in the market	P/E Price per share divided by earnings per share	ROE Net income divided by shareholder equity	ROCE Earnings before interest and tax divided by capital employed	Debt/Eq Total debt divided by total equity	Profit 5Y Average annual profit growth over 5 years	Sales 5Y Average annual sales growth over 5 years	Dividend Annual dividend per share divided by price per share
TruAlt BioenergyTruAlt Bioenerg...Selected✓ TRUALT • 544545	0/100	₹477.05₹477	₹3668.07₹3668.07	38.23Average 38.2 Average	8.38%Poor 8.38% Poor	10.44%Average 10.44% Average	1.09Average 1.1 Average	— —	— —	0.00%
LT Foods LtdLT Foods Ltd... LTFOODS • 532783	59.6/100	₹410.35₹410	₹13456.58₹13456.58	21.52Average 21.5 Average	14.94%Average 14.94% Average	17.74%Good 17.74% Good	0.36Excellent 0.4 Excellent	17.99%Excellent 17.99% Excellent	18.70%Excellent 18.70% Excellent	0.78%
KRBL LtdKRBL Ltd... KRBL • 530813	45.2/100	₹351.10₹351	₹8204.32₹8204.32	12.66Average 12.7 Average	11.73%Average 11.73% Average	15.16%Good 15.16% Good	0.03Excellent 0.0 Excellent	3.00%Average 3.00% Average	8.84%Good 8.84% Good	0.97%
Gujarat Ambuja Exports LtdGujarat Ambuja ... GAEL • 524226	45.1/100	₹172.11₹172	₹6852.99₹6852.99	22.30Average 22.3 Average	9.76%Poor 9.76% Poor	12.51%Average 12.51% Average	0.13Excellent 0.1 Excellent	-1.98%Poor -1.98% Poor	4.01%Average 4.01% Average	0.17%
Kaveri Seed Company LimitedKaveri Seed Com... KSCL • 532899	51.8/100	₹782.45₹782	₹4345.35₹4345.35	14.69Average 14.7 Average	18.17%Good 18.17% Good	18.79%Good 18.79% Good	0.00Excellent 0.0 Excellent	0.76%Average 0.76% Average	6.18%Good 6.18% Good	0.59%
Sanstar LtdSanstar Ltd... SANSTAR • 544217	39.7/100	₹111.75₹112	₹2204.51₹2204.51	63.99Average 64.0 Average	5.09%Poor 5.09% Poor	5.69%Poor 5.69% Poor	0.03Excellent 0.0 Excellent	19.99%Excellent 19.99% Excellent	19.85%Excellent 19.85% Excellent	0.00%
Grm Overseas LtdGrm Overseas Lt... GRMOVER • 531449	40.4/100	₹89.73₹90	₹1908.68₹1908.68	25.67Average 25.7 Average	14.47%Average 14.47% Average	13.99%Average 13.99% Average	0.61Good 0.6 Good	10.46%Good 10.46% Good	18.11%Excellent 18.11% Excellent	0.00%
Chaman Lal Setia Exp LtdChaman Lal Seti... CLSEL • 530307	54.6/100	₹285.50₹286	₹1389.83₹1389.83	12.11Average 12.1 Average	14.61%Average 14.61% Average	18.32%Good 18.32% Good	0.10Excellent 0.1 Excellent	6.95%Good 6.95% Good	11.07%Good 11.07% Good	0.89%
Gulshan Polyols LtdGulshan Polyols... GULPOLY • 532457	58.1/100	₹197.32₹197	₹1131.69₹1131.69	10.55Average 10.6 Average	16.11%Good 16.11% Good	18.31%Good 18.31% Good	0.44Excellent 0.4 Excellent	11.71%Good 11.71% Good	24.73%Excellent 24.73% Excellent	0.17%
Avt Natural Products LtdAvt Natural Pro... AVTNPL • 519105	58.2/100	₹71.47₹71	₹1079.35₹1079.35	16.65Average 16.6 Average	12.16%Average 12.16% Average	14.22%Average 14.22% Average	0.20Excellent 0.2 Excellent	7.57%Good 7.57% Good	8.01%Good 8.01% Good	1.13%
Bombay Super Hybrid Seeds LtdBombay Super Hy... BSHSL •	53.4/100	₹85.00₹85	₹901.37₹901.37	33.81Average 33.8 Average	22.62%Excellent 22.62% Excellent	15.97%Good 15.97% Good	0.83Good 0.8 Good	35.95%Excellent 35.95% Excellent	15.04%Excellent 15.04% Excellent	0.00%

Top Other Agricultural Products Stocks

View all →

By Bull Run Score

By Return on Equity

Bombay Super Hybrid Seeds Ltd share price22.62%
Kaveri Seed Company Limited share price18.17%
Gulshan Polyols Ltd share price16.11%
LT Foods Ltd share price14.94%
Chaman Lal Setia Exp Ltd share price14.61%

By Market Cap

LT Foods Ltd share price13456.58 Cr
KRBL Ltd share price8204.32 Cr
Gujarat Ambuja Exports Ltd share price6852.99 Cr
Kaveri Seed Company Limited share price4345.35 Cr
Sanstar Ltd share price2204.51 Cr

TruAlt Bioenergy Quarterly Performance

Latest quarterly metrics for TRUALT — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-34.34%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-46.39%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

TruAlt Bioenergy Technical Indicators

SMA 50, SMA 200, RSI and volume signals for TRUALT — calculated from daily price history

Neutral — RSI 36

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹468

▲ Price above SMA 50 — Short-term bullish

SMA 200

₹436

▲ Price above SMA 200 — Long-term uptrend

30-Day Avg Volume

285K shares/day

Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

TruAlt Bioenergy Financial Statements

Annual income statement, balance sheet and cash flow for TruAlt Bioenergy (TRUALT) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for TruAlt Bioenergy

About TRUALT (TruAlt Bioenergy)

TruAlt Bioenergy (TRUALT) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Other Agricultural Products sector wi...th a current market capitalisation of ₹3.67K (Cr). TruAlt Bioenergy has delivered a Return on Equity (ROE) of 8.38% and a ROCE of 10.44%. The debt-to-equity ratio stands at 1.09, reflecting the company's capital structure. Investors tracking TRUALT share price can monitor key metrics including P/E ratio, promoter holding of 70.55%, and quarterly earnings growth.

Company Details

Symbol:TRUALT

Industry:Other Agricultural Products

Sector:N/A

Website:N/A

TRUALT Share Price: Frequently Asked Questions

What is the current share price of TruAlt Bioenergy?

TruAlt Bioenergy (TRUALT) trades at ₹477.05 on NSE and BSE. Market cap ₹3.67K (Cr). Educational data only.

What is the P/E ratio of TruAlt Bioenergy?

TruAlt Bioenergy has a P/E of 38.23x vs industry average 19.03x.

What is the Bull Run score for TruAlt Bioenergy?

TruAlt Bioenergy has a Bull Run score of 0/100 based on 25+ financial parameters.

Does TruAlt Bioenergy pay dividends?

TruAlt Bioenergy has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of TruAlt Bioenergy?

TruAlt Bioenergy has ROE of 8.38%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of TruAlt Bioenergy?

TruAlt Bioenergy has debt-to-equity of 1.09.

Is TruAlt Bioenergy a good investment?

Bull Run gives TruAlt Bioenergy a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.